Regenxbio Completes Dosing in Confirmatory Study of Rgx-202, Marking Completion of Registrational Development Program and Supporting Planned Bla Submission in Q3 2026 PR Newswire (Press Release) 3d
FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy Pharmaceutical Technology 3d
Moderna’s mRNA flu vaccine passes FDA AdCom, review underway Pharmaceutical Technology 5d Moderna mRNA Flu All sources
FDA reports efforts prevented 450K youth from vaping Tobacco Reporter Magazine 2d Vaping Tobacco All sources
Cheese sold in NJ recalled amid listeria concerns, FDA says Patch 10h Listeria Maryland New Jersey All sources
